6-((CYCLOPROPYLCARBONYL)AMINO)-4-((3-(5-(DICYCLOPROPYLPHOSPHINYL)-1-METHYL-1H-PYRAZOL-3-YL)-2-METHOXYPHENYL)AMINO)-N-METHYL-3-PYRIDAZINECARBOXAMIDE
UNII MF65PU8W65
Substance Identification & Data
This profile provides standardized clinical and technical data for 6-((cyclopropylcarbonyl)amino)-4-((3-(5-(dicyclopropylphosphinyl)-1-methyl-1h-pyrazol-3-yl)-2-methoxyphenyl)amino)-n-methyl-3-pyridazinecarboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MF65PU8W65.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2903427-58-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C27H32N7O4P SDZVMHGMNIWMHH-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6-((cyclopropylcarbonyl)amino)-4-((3-(5-(dicyclopropylphosphinyl)-1-methyl-1h-pyrazol-3-yl)-2-methoxyphenyl)amino)-n-methyl-3-pyridazinecarboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.